RCZY-711

N/A

Report date: 2025/07/08 14:51:49
NME

Base Information

Drug NameRCZY-711
Drug Alias NameRCZY-711
ClassificationOther
Mechanisms of ActionMenin/Histone-lysine N-methyltransferase 2A MLL inhibitors
TargetsMeninHistone-lysine N-methyltransferase 2A
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRongchang Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRongchang Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A